{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:43:41Z","timestamp":1778582621994,"version":"3.51.4"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:p>Gynecologic cancers are common in the United States and represent a significant health burden. Treatment of these cancers often causes premature cessation of ovarian function, with resultant symptoms that are often more severe than those associated with natural menopause. Hormone therapy is the most effective treatment for menopausal symptoms, but the decision-making process about its use can be complex for survivors of gynecologic cancer. In this review, we provide evidence-based recommendations about the use of hormone therapy after gynecologic cancer.<\/jats:p>","DOI":"10.1097\/grf.0000000000000381","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T23:30:15Z","timestamp":1526427015000},"page":"488-495","source":"Crossref","is-referenced-by-count":6,"title":["Menopausal Hormone Therapy in Gynecologic Cancer Survivors: A Review of the Evidence and Practice Recommendations"],"prefix":"10.1097","volume":"61","author":[{"given":"EKTA","family":"KAPOOR","sequence":"first","affiliation":[{"name":"Women\u2019s Health Clinic, Division of General Internal Medicine"},{"name":"Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DANIEL","family":"BENRUBI","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Fox Chase Cancer Center at Temple University Hospital, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"STEPHANIE S.","family":"FAUBION","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Clinic, Division of General Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20230911","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/jwh.2013.4465","article-title":"Gynecologic cancer prevention and control in the National Comprehensive Cancer Control Program: progress, current activities, and future directions","volume":"22","author":"Stewart","year":"2013","journal-title":"J Womens Health (Larchmt)"},{"key":"R3-20230911","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/GME.0000000000000921","article-title":"The 2017 hormone therapy position statement of The North American Menopause Society","volume":"24","year":"2017","journal-title":"Menopause"},{"key":"R4-20230911","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.fertnstert.2005.10.033","article-title":"Type of menopause, patterns of hormone therapy use, and hot flashes","volume":"85","author":"Gallicchio","year":"2006","journal-title":"Fertil Steril"},{"key":"R5-20230911","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy","volume":"24","author":"Madalinska","year":"2006","journal-title":"J Clin Oncol"},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/13697137.2015.1020484","article-title":"Long-term health consequences of premature or early menopause and considerations for management","volume":"18","author":"Faubion","year":"2015","journal-title":"Climacteric"},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1258\/mi.2008.008016","article-title":"Prophylactic oophorectomy in premenopausal women and long-term health","volume":"14","author":"Shuster","year":"2008","journal-title":"Menopause Int"},{"key":"R8-20230911","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.maturitas.2009.08.003","article-title":"Premature menopause or early menopause: long-term health consequences","volume":"65","author":"Shuster","year":"2010","journal-title":"Maturitas"},{"key":"R9-20230911","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMcp0808697","article-title":"Clinical practice. Primary ovarian insufficiency","volume":"360","author":"Nelson","year":"2009","journal-title":"N Engl J Med"},{"key":"R10-20230911","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1258\/175404507780456719","article-title":"Management of premature menopause","volume":"13","author":"Pitkin","year":"2007","journal-title":"Menopause Int"},{"key":"R12-20230911","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.maturitas.2009.11.017","article-title":"Hormone replacement after gynaecological cancer","volume":"65","author":"Singh","year":"2010","journal-title":"Maturitas"},{"key":"R13-20230911","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/aje\/kwq300","article-title":"Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition","volume":"172","author":"Allen","year":"2010","journal-title":"Am J Epidemiol"},{"key":"R14-20230911","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Endometrial cancer and hormone-replacement therapy in the Million Women Study","volume":"365","author":"Beral","year":"2005","journal-title":"Lancet"},{"key":"R15-20230911","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ijc.24672","article-title":"Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses\u2019 Health Study cohort 1976-2004","volume":"126","author":"Karageorgi","year":"2010","journal-title":"Int J Cancer"},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women\u2019s Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/ijc.29878","article-title":"The influence of hormone therapies on type I and II endometrial cancer: a nationwide cohort study","volume":"138","author":"Morch","year":"2016","journal-title":"Int J Cancer"},{"key":"R18-20230911","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.ejca.2014.09.003","article-title":"Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions","volume":"50","author":"Tangen","year":"2014","journal-title":"Eur J Cancer"},{"key":"R19-20230911","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.ejca.2007.08.014","article-title":"Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas","volume":"43","author":"Shabani","year":"2007","journal-title":"Eur J Cancer"},{"key":"R20-20230911","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0360-3016(89)90365-9","article-title":"The predictive value of progesterone receptor levels in endometrial cancer","volume":"17","author":"Ingram","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R21-20230911","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study","volume":"24","author":"Barakat","year":"2006","journal-title":"J Clin Oncol"},{"key":"R22-20230911","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/cncr.23717","article-title":"Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy?","volume":"113","author":"Maxwell","year":"2008","journal-title":"Cancer"},{"key":"R23-20230911","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0002-9378(96)70027-3","article-title":"Estrogen replacement in surgical stage I and II endometrial cancer survivors","volume":"175","author":"Chapman","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R24-20230911","first-page":"326","article-title":"Estrogen replacement therapy in the patient treated for endometrial cancer","volume":"67","author":"Creasman","year":"1986","journal-title":"Obstet Gynecol"},{"key":"R25-20230911","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0090-8258(90)90171-G","article-title":"Estrogen replacement therapy following treatment for stage I endometrial carcinoma","volume":"36","author":"Lee","year":"1990","journal-title":"Gynecol Oncol"},{"key":"R26-20230911","first-page":"555","article-title":"Estrogen replacement therapy in endometrial cancer patients: a matched control study","volume":"97","author":"Suriano","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R27-20230911","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1525-1438.2006.00526.x","article-title":"Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors?","volume":"16","author":"Ayhan","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R28-20230911","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejca.2014.03.006","article-title":"Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis","volume":"50","author":"Shim","year":"2014","journal-title":"Eur J Cancer"},{"key":"R29-20230911","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"suppl 2","key":"R31-20230911","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/S0020-7292(12)60025-3","article-title":"Cancer of the ovary, fallopian tube, and peritoneum","volume":"119","author":"Berek","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"issue":"pt A","key":"R32-20230911","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.steroids.2014.12.013","article-title":"Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers","volume":"99","author":"Brown","year":"2015","journal-title":"Steroids"},{"key":"R33-20230911","first-page":"95","article-title":"Noncontraceptive estrogen use and the occurrence of ovarian cancer","volume":"68","author":"Weiss","year":"1982","journal-title":"J Natl Cancer Inst"},{"key":"R34-20230911","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jama.2009.1052","article-title":"Hormone therapy and ovarian cancer","volume":"302","author":"Morch","year":"2009","journal-title":"JAMA"},{"key":"R35-20230911","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/jnci\/djj375","article-title":"Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort","volume":"98","author":"Lacey","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R36-20230911","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/humupd\/dmm012","article-title":"Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis","volume":"13","author":"Greiser","year":"2007","journal-title":"Hum Reprod Update"},{"key":"R37-20230911","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ygyno.2007.12.003","article-title":"Hormone replacement therapy and ovarian cancer risk: a meta-analysis","volume":"108","author":"Zhou","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R38-20230911","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bjc.6603527","article-title":"A prospective study of postmenopausal hormone use and ovarian cancer risk","volume":"96","author":"Danforth","year":"2007","journal-title":"Br J Cancer"},{"key":"R39-20230911","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(07)60534-0","article-title":"Ovarian cancer and hormone replacement therapy in the Million Women Study","volume":"369","author":"Beral","year":"2007","journal-title":"Lancet"},{"key":"R40-20230911","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies","volume":"385","author":"Beral","year":"2015","journal-title":"Lancet"},{"key":"R41-20230911","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ygyno.2015.07.109","article-title":"Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis","volume":"139","author":"Li","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R42-20230911","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.maturitas.2016.07.018","article-title":"Menopausal hormone therapy in cancer survivors: a narrative review of the literature","volume":"92","author":"Kuhle","year":"2016","journal-title":"Maturitas"},{"key":"R43-20230911","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.22357","article-title":"Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies","volume":"120","year":"2007","journal-title":"Int J Cancer"},{"key":"R44-20230911","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/GME.0000000000000357","article-title":"Hormone therapy after uterine cervical cancer treatment: a Swedish population-based study","volume":"22","author":"Everhov","year":"2015","journal-title":"Menopause"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201809000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:15:12Z","timestamp":1694420112000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201809000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000381","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}